Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Specific Phobia
NCT00121069Phase 3Completed
- Start
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in specific phobia. Started Sep 2002; status: completed.
02
Drugs
escitalopram
03
Conditions
specific phobia
Beyond the preview
Go deeper on NCT00121069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121069.